SCIRT and lung cancer: In addition, we identified that plasma exosomal miR-665 and SCIRT are significantly upregulated in lung cancer patients and correlated with the advanced stage of the disease, therefore indicating a diagnostic and prognostic potential of the regulatory pathway.